Activating the immune system to Pheast on cancer
Pheast Therapeutics is a cancer immunotherapy company focused on developing novel checkpoint therapies to harness the innate immune system in the fight against cancer.
Learn More Scroll
Our Leadership
Jacopo Leonardi
Chief Executive Officer, Board Director
Amira Barkal, MD, PhD
Principal Founder, Chief Development Officer, Board Director
Roy Maute, PhD
Cofounder, Chief Scientific Officer
Irving Weissman, MD
Cofounder, Scientific Advisor, Board Director
Ravi Majeti, MD, PhD
Cofounder, Scientific Advisor, and Board Observer
Steve Gillis, PhD
Board Director
R. Jacob Vogelstein, PhD
Board Director
